Firefly Neuroscience (AIFF) Stock Analysis & AI Equity Report

Software - Application USD Explore free reports

Firefly Neuroscience (AIFF) overview

Firefly Neuroscience (AIFF) stock analysis and AI equity research. For financial year 2025, Valuatum's model shows revenue of USD 1.1m and operating profit of USD -8.9m; the year-end share price was 0.88 USD and market capitalisation was USD 12.3m. Firefly Neuroscience is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Firefly Neuroscience's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.

Key metrics & valuation multiples

Book valueUSD 7.6mFY 2025
Share price0.88 USDFY 2025 year end
RevenueUSD 1.1mFY 2025
Operating profitUSD -8.9mFY 2025
Net earningsUSD -19.9mFY 2025
Market capitalisationUSD 12.3mFY 2025 year end

About Firefly Neuroscience

Firefly Neuroscience develops an integrated hardware, software, and data platform for clinical electrophysiological assessment. Its Evoke System captures EEG and ERP data, which its cloud-based analytics platform analyzes and returns to clinicians in structured reports. The system is used at clinical sites in the United States, where providers use its assessments and reports to support clinical decision-making about brain health.

Generate the Firefly Neuroscience report

Firefly Neuroscience is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.

Generate fresh report — €50.00 Delivered by email, usually within an hour

Sources & methodology

Financial figures are sourced from Valuatum's financial model for Firefly Neuroscience and represent financial year 2025. See the methodology for the full Valuatum AI equity research framework.

Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.

Analyst reports on Firefly Neuroscience

Each report here is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by a score out of five: what other analysts felt the work added over the engine's default report.